Production of betulin and betulinum containing supplements (dietary supplements) for humans and animals

Project description

The project of production of betulin from woodworking production waste.

Stage 1. Production of betulin

The start of production of betulin according to a unique technology developed by the Institute of Chemistry of the Russian Academy of Sciences. From the moment of investing 4-5 months before the start of production and the start of sales of betulin, as a substance for medicines and dietary supplements.

Stage 2. Production of betulin-containing feed additives for animals.

Currently, the Kostroma Agricultural Academy carries out the tests on animals in order to develop the optimal formulation for the production of betulin-containing animal feed additives. Each additive will be protected by a patent. Implementation time is approximately 1 year.

Stage 3. Production of betulinum-containing medicines and dietary supplements for people.

Part of the work has already been done by the Pyatigorsk Pharmaceutical Institute. Preclinical and clinical studies of preparations are required, of which the constituent is betulin of its own production. Realization time from 1 year to 2 years.

Additional information

Currently, betulin has 16 proven properties, positively affecting the activity of the body. First of all, it is anti-inflammatory, antiseptic, hepatoprotective, choleretic, antilithogenic, antioxidant, antitumor, antiviral, gastroprotective, vasodilating, antimutogenic, etc. It is not without reason that it is called the "cure for death". This allows you to make on its basis medicines and supplements of a wide spectrum of action. And, since this drug has a natural origin, it has virtually no adverse side effects.

Most recently, it was also discovered in veterinary medicine. On its basis, medicines began to be made, significantly increasing the index of keeping the herd of young animals.

Market analytics

The market of betulin in Russia is about 3,000 kg per month, another 1,000 kg is exported. At our plant can produce up to 150 kg per month, i.е. this is approximately 4% of the market.

The world market of betulin is about 20 times larger than Russian and is about 60-70 tons per month. The main players on it are companies from China, the USA, Russia and Canada. At the same time, almost 80% of the world park of birches is located on the territory of the Russian Federation.

The features of our technology, as well as the abundance of raw materials, make it possible to obtain betulin with a cost, one of the lowest in the world.

In the past 2-3 years, we see a strong growth in the market for betulin, about 20-30% per year. The main factor in this demand was the discovery of its new properties, especially such as antitumor (including malignant tumors), antioxidant, antimutagenic, hepatoprotective, antilithogenic. In addition, its growth is affected by its high efficiency and the complexity of preparations based on it.

The uniqueness of the project

Our technology for the production of betulin is developed by the Institute of Chemistry and Chemical Technologies of the Russian Academy of Sciences and is unique. Its peculiarity is that it uses the hydrolysis method, which allows extracting from birch bark not only betulin, but also all other useful components. First of all, it is suberin, and also betulinic and suberic acid. These are substances that are in high demand on the world pharmaceutical market.

Monetization sources

1. Sale of betulin as a substance. In practice, this is an exchange trade.

2. Development of the veterinary direction, development of feed additives based on betulin, increasing the index of preservation of the young herd. Creation of a veterinary brand.

3. Development and sale of betulin-containing drugs and supplements under its own brand. Development of the brand, increasing its recognition, trust in it, loyalty.

Sales strategy and marketing

1. At the first stage, sales go to pharmaceutical companies. Sales organization b2b, and have, in practice, a kind of exchange trade.

2. The second stage develops its own preparations under a unique brand, and creates a line of unique products, both in veterinary medicine and in medicine. Sales go through pharmacy and veterinary networks.

Project detailed information is available to investors after authorization.

Project detailed information is available to investors after authorization.

Translated by "Yandex.Translator"
Project No. 28907
Created on: 10.07.2018

Russia, Tyumen region, Tyumen


Project price: 10 435 000

Investments volume: 145 000


Stage: Idea


Website: бетулайф.рф - доступен, www.betulife.ru - в разработке


1307 reviews

Contact details of entrepreneur

Russia, Tyumen region, Tyumen
Biotechnologies, Medicine/ pharmaceutics, Chemical industry, Agriculture